Showing 9101-9110 of 20379 results for "".
- Finding a Solution for Long COVID, One Cell Type at a Timehttps://reachmd.com/news/finding-a-solution-for-long-covid-one-cell-type-at-a-time/2467482/A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal gr
- Mayo Clinic Scientists Define New Type of Memory Loss in Older Adultshttps://reachmd.com/news/mayo-clinic-scientists-define-new-type-of-memory-loss-in-older-adults/2467425/ROCHESTER, Minn. — Researchers at Mayo Clinic have established new criteria for a memory-loss syndrome in older adults that specifically impacts the brain's limbic system. It can often be mistaken for Alzheimer's disease. The good new
- A Type of Allergy Medicine Might Help Treat Lung Cancerhttps://reachmd.com/news/a-type-of-allergy-medicine-might-help-treat-lung-cancer/2456740/Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC). And in an early parallel study in humans, combining immunothe
- A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggestshttps://reachmd.com/news/a-type-of-allergy-medicine-might-help-treat-lung-cancer-research-suggests/2456702/New York, NY (December 06, 2023) Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC)<
- Targeting Kdm6a in Microglia Reverses MS-Like Disease in Female Micehttps://reachmd.com/news/targeting-kdm6a-in-microglia-reverses-ms-like-disease-in-female-mice/2483976/A new study suggests that a gene located on the X chromosome—Kdm6a—may play a key role in the increased susceptibility of women to multiple sclerosis (MS). Researchers found that deleting this gene specifically in microglia, t
- Reversing Vision Loss in Macular Degeneration: Stem Cell Therapy's Promisehttps://reachmd.com/news/reversing-vision-loss-in-macular-degeneration-stem-cell-therapys-promise/2483532/Macular degeneration relentlessly chips away at vision, yet recent strides in stem cell therapy offer cautious hope based on early-stage clinical studies and preclinical work. Understanding how these investigational approaches may support or rejuvenate damaged tissues is reshaping e
- Human Longevity Lab Will Study Methods to Slow or Reverse Aging - News Centerhttps://reachmd.com/news/human-longevity-lab-will-study-methods-to-slow-or-reverse-aging-news-center/2467331/Scientists want to develop ways to improve human lifespan, so people live longer, healthier lives A comprehensive research protoc
- Gold Nanoparticles Reverse Brain Deficits in Multiple Sclerosis, Parkinson’shttps://reachmd.com/news/gold-nanoparticles-reverse-brain-deficits-in-multiple-sclerosis-parkinsons/2462818/Gold nanocrystals suspended in a water buffer represent a novel therapeutic agent developed by Clene Nanomedicine for neurodegenerative conditions. This nanomedicine, called CNM-Au8, is being investigated to treat patients with multiple sclerosis and Parkinson’s disease in cl
- Brolucizumab in Condor Trial for Proliferative Diabetic Retinopathyhttps://reachmd.com/news/brolucizumab-in-condor-trial-for-proliferative-diabetic-retinopathy/2487676/Key Takeaways Week 54 visual acuity preservation favored brolucizumab over panretinal photocoagulation. No proliferative diabetic retinopathy at week 54 was reported in 63.6% of brolucizumab-treated patients and 22.4% of PRP-treated patients.
- Addressing Cultural Gaps in Diabetes Prevention and Self-Managementhttps://reachmd.com/news/cultural-gaps-diabetes-prevention-management/2485616/Vietnamese American adults at risk for diabetes may feel motivated to change diet and activity habits yet report low readiness to enroll in formal prevention and management programs. A